Orfadin Articles
Synosia initiates proof-of-concept nitisinone study in RLS
22 December 2008
Synosia initiates Ph IIa trial of PD drug
14 July 2008
Synosia acquires HPPD inhibitor from Syngenta
28 May 2007
Orphan drug cleared for rare liver disease
28 January 2002
Showing 1-6 of 6 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Italy's pharma market slump set to continue, warns GlobalData
- Pfizer to split-off remaining 80% interest in Zoetis
